WHO ICTRP trial
Phase II clinical trial of combination therapy with medium-chain triglycerides…
JPRN-UMIN000015222 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000015222 |
|---|---|
| Public title | Phase II clinical trial of combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease |
| Scientific title | Phase II clinical trial of combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease - Therapy with medium-chain triglycerides and ghrelin for chronic obstructive pulmonary disease |
| Primary sponsor | National Hospital Organization Toneyama National Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | COPD |
| Interventions | 1) Administration of edible oil consisting of medium-chain C8 triglyceride (octanoic acid) 5 g of edible oil consisting of medium-chain C8 triglyceride will be administered orally, twice daily, for 26 days (at breakfast and at lunch). 2)… |
| Registration date | Jan 10, 2014 |
| Target size | 10 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: